Hartland & Co »

Lenz Therapeutics shares owned by Hartland & Co

Quarter-by-quarter ownership of Lenz Therapeutics (LENZ) shares owned by Hartland & Co from 13F filings

Historical chart of Hartland & Co investment in Lenz Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lenz Therapeutics held by Hartland & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lenz Therapeutics by Hartland & Co

Quarter filed Position value Share count Share price at filing
2026-06-30 $6 1 6.00

More positions owned by Hartland & Co

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core S&p500 Etf (IVV)
Apple Put Put Option (Principal) (AAPL)
Paccar (PCAR)
Ishares Tr Rus 1000 Grw Etf (IWF)
Vanguard Index Fds Mid Cap Etf (VO)
Microsoft Corporation (MSFT)
Vanguard Index Fds Small Cp Etf (VB)
Vanguard Index Fds Value Etf (VTV)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Spdr Index Shs Fds St Str Po Ex Etf (SPDW)
Amazon Call Call Option (AMZN)
Vanguard Scottsdale Fds Mtg-bkd Secs Etf (VMBS)
Ishares Tr Core Msci Intl (IDEV)
Vanguard Index Fds Call Call Option (VTI)

View all positions for Hartland & Co

Top funds holding Lenz Therapeutics

RA Capital Management
Falcon Edge Capital
FMR
Versant Venture Management
BlackRock
Squarepoint Ops
Standard Life Aberdeen
Millennium Management
Vanguard Capital Management
72 Investment Holdings
Blue Owl Capital Holdings
CAM Group Holding A/S
Morgan Stanley
Citadel Advisors
Geode Capital Management

View all funds holding Lenz Therapeutics